References
- Docherty B. Skeletal system. Part one–bone structure. Nurs Times [Internet]. 103:28–29. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17319304
- Frassica FJ, Inoue N, Virolainen P, et al. Skeletal system: biomechanical concepts and relationships to normal and abnormal conditions. Semin Nucl Med [Internet]. 1997;27:321–327. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9364641
- Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem [Internet]. 2010;285:25103–25108. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20501658
- Rowe P, Sharma S. Physiology, bone remodeling [Internet]. StatPearls. Treasure Island (FL): StatPearls Publishing; 2019. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29763038
- US Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. US Heal. Hum. Serv. [Internet]; 2004 [cited 2020 Jan 14]. 437. Available from: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Bone+Health+and+Osteoporosis+A+Report+of+the+Surgeon+General#0
- Sinusas K. Osteoarthritis: diagnosis and treatment. Am Fam Physician [Internet]. 2012;85:49–56. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22230308
- Chen D, Shen J, Zhao W, et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res [Internet]. 2017;5:16044. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28149655
- Rosen CJ The epidemiology and pathogenesis of osteoporosis [Internet]. Endotext. MDText.com, Inc.; 2000 [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25905357
- Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol [Internet]. 2017;4:46–56. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28293453
- Fritz JM, McDonald JR. Osteomyelitis: approach to diagnosis and treatment. Phys Sportsmed [Internet]. 2008;36:nihpa116823. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19652694
- Momodu II, Savaliya V. Osteomyelitis [Internet]. StatPearls. StatPearls Publishing; 2019 [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30335283
- Durfee RA, Mohammed M, Luu HH. Review of osteosarcoma and current management. Rheumatol Ther [Internet]. 2016;3:221–243. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27761754
- Misaghi A, Goldin A, Awad M, et al. Osteosarcoma: a comprehensive review. Sicot J [Internet]. 2018;4:12. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29629690
- van Dijk FS, Cobben JM, Kariminejad A, et al. Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol [Internet]. 2011;2:1–20. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22570641
- Sam JE, Dharmalingam M. Osteogenesis imperfecta. Indian J Endocrinol Metab [Internet]. 2017;21:903–908. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29285457
- Stapleton M, Sawamoto K, Alméciga-Díaz CJ, et al. Development of bone targeting drugs. Int J Mol Sci. 2017;18:1345.
- Luhmann T, Germershaus O, Groll J, et al. Bone targeting for the treatment of osteoporosis. J Control Release. 2012;161:198–213.
- Carbone EJ, Rajpura K, Allen BN, et al. Osteotropic nanoscale drug delivery systems based on small molecule bone-targeting moieties. Nanomedicine Nanotechnology, Biol Med. 2017;13:37–47.
- Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008;83:1032–1045.
- Heymann D. Bisphosphonates and bone diseases: past, present and future. Curr Pharm Des. 2010;16:2948–2949.
- Uludag H. Bisphosphonates as a foundation of drug delivery to bone. Curr Pharm Des [Internet]. 2002;8:1929–1944. [cited 2019 Jul 2]. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1381-6128&volume=8&issue=21&spage=1929
- Cole LE, Vargo-Gogola T, Roeder RK. Targeted delivery to bone and mineral deposits using bisphosphonate ligands. Adv Drug Deliv Rev [Internet]. 2016;99:12–27. [cited 2019 Jul 2]. Available from: https://www.sciencedirect.com/science/article/pii/S0169409X15002306
- Billon-Chabaud A, Gouyette A, Merle C, et al. Development of bisphosphonates controlled delivery systems for bone implantation: influence of the formulation and process used on in vitro release. J Mater Sci Mater Med [Internet]. 2010;21:1599–1604. [cited 2019 Jul 2]. Available from: http://link.springer.com/10.1007/s10856-010-4012-x
- Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65:232–260. second page, table of contents.
- Demers P, Fraser D, Goldbloom RB, et al. Effects of tetracyclines on skeletal growth and dentition. A report by the nutrition committee of the Canadian paediatric society. Can Med Assoc J. 1968;99:849–854.
- Payne JB, Golub LM. Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic. Pharmacol Res. 2011;63:121–129.
- Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for the local delivery of antibiotics in bone infections. Drugs [Internet]. 2000;59:1223–1232. [cited 2019 Jul 2]. Available from: http://link.springer.com/10.2165/00003495-200059060-00003
- Mombelli A, Feloutzis A, Bragger U, et al. Treatment of peri-implantitis by local delivery of tetracycline. Clinical, microbiological and radiological results. Clin Oral Implants Res [Internet]. 2001;12:287–294. [cited 2019 Jul 2]. Available from: http://doi.wiley.com/10.1034/j.1600-0501.2001.012004287.x
- Domingues ZR, Cortés ME, Gomes TA, et al. Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with β-cyclodextrin. Biomaterials [Internet]. 2004;25:327–333. [cited 2019 Jul 2]. Available from: https://www.sciencedirect.com/science/article/pii/S0142961203005246
- Wang H, Liu J, Tao S, et al. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system. Int J Nanomedicine [Internet]. 2015;10:5671–5685. [cited 2019 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26388691
- Xie Y, Liu C, Huang H, et al. Bone-targeted delivery of simvastatin-loaded PEG-PLGA micelles conjugated with tetracycline for osteoporosis treatment. Drug Deliv Transl Res [Internet]. 2018;8:1090–1102. [cited 2019 Jul 2]. Available from: http://link.springer.com/10.1007/s13346-018-0561-1
- Takahashi-Nishioka T, Yokogawa K, Tomatsu S, et al. Targeted drug delivery to bone: pharmacokinetic and pharmacological properties of acidic oligopeptide-tagged drugs. Curr Drug Discov Technol. 2008;5:39–48.
- Sekido T, Sakura N, Higashi Y, et al. Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential. J Drug Target. 2001;9:111–121.
- Sekido T, Sakura N, Higashi Y, et al. Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential. J Drug Target [Internet]. 2001;9:111–121. [cited 2019 Jul 2]. Available from: http://www.tandfonline.com/doi/full/10.3109/10611860108997922
- Ishizaki J, Waki Y, Takahashi-Nishioka T, et al. Selective drug delivery to bone using acidic oligopeptides. J Bone Miner Metab [Internet]. 2009;27:1–8. [cited 2019 Jul 1]. Available from: http://link.springer.com/10.1007/s00774-008-0004-z
- Miyamoto K, Takahashi-Nishioka T, Yokogawa K, et al. Targeted drug delivery to bone: pharmacokinetic and pharmacological properties of acidic oligopeptide-tagged drugs. Curr Drug Discov Technol [Internet]. 2008;5:39–48. [cited 2019 Jul 2]. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1570-1638&volume=5&issue=1&spage=39
- Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov [Internet]. 2017;16:181–202. [cited 2019 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27807347
- Newman MR, Benoit DS. Local and targeted drug delivery for bone regeneration. Curr Opin Biotechnol [Internet]. 2016;40:125–132. [cited 2019 Jul 2]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27064433
- Chen L, He W, Jiang H, et al. In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model. Int J Nanomedicine [Internet]. 2018;14:149–159. [cited 2019 Jul 2]. Available from: https://www.dovepress.com/in-vivo-selex-of-bone-targeting-aptamer-in-prostate-cancer-bone-metast-peer-reviewed-article-IJN
- Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol [Internet]. 2011;6:121–145. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20936937
- Xinluan W, Yuxiao L, Helena NH, et al. Systemic drug delivery systems for bone tissue regeneration- a mini review. Curr Pharm Des [Internet]. 2015;21:1575–1583. Available from:: http://www.ncbi.nlm.nih.gov/pubmed/25594406
- Alencastre I, Sousa D, Alves C, et al. Delivery of pharmaceutics to bone: nanotechnologies, high-throughput processing and in silico mathematical models. Eur Cells Mater. 2016;31:355–381.
- Walmsley GG, McArdle A, Tevlin R, et al. Nanotechnology in bone tissue engineering. Nanomedicine [Internet]. 2015;11:1253–1263. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25791811
- Yi H, Ur Rehman F, Zhao C, et al. Recent advances in nano scaffolds for bone repair. Bone Res [Internet]. 2016;4:16050. [cited 2019 Jul 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28018707
- Mostafavi E, Soltantabar P and Webster TJ. Nanotechnology and picotechnology: a new arena for translational medicine. In Biomaterials in Translational Medicine. Academic Press. 2019. p. 191–212. Available from: https://www.sciencedirect.com/science/article/pii/B9780128134771000098
- Chun YW, Webster TJ. The role of nanomedicine in growing tissues. Ann Biomed Eng. 2009;37:2034–2047.
- Cheng H, Chawla A, Yang Y, et al. Development of nanomaterials for bone-targeted drug delivery. Drug Discov Today [Internet]. 2017;22:1336–1350. [cited 2019 Jul 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28487069
- Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release [Internet]. 2012;164:138–144. [cited 2019 Jul 25]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22595146
- Bose S, Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater. 2012;8:1401–1421.
- Bosco R, Iafisco M, Tampieri A, et al. Hydroxyapatite nanocrystals functionalized with alendronate as bioactive components for bone implant coatings to decrease osteoclastic activity. Appl Surf Sci. 2015;328:516–524.
- Yi C, Liu D, Fong CC, et al. Gold nanoparticles promote osteogenic differentiation of mesenchymal stem cells through p38 MAPK pathway. ACS Nano. 2010;4:6439–6448.
- Ghosh P, Han G, De M, et al. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60:1307–1315.
- Mehranfar S, Abdi Rad I, Mostafavi E, et al. The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials. Cells Nanomed Biotechnol. 2019;47:882–890.
- Lee D, Heo DN, Kim HJ, et al. Inhibition of osteoclast differentiation and bone resorption by bisphosphonate-conjugated gold nanoparticles. Sci Rep. 2016;6(1):1–11.
- Behzadi S, Luther GA, Harris MB, et al. Nanomedicine for safe healing of bone trauma: opportunities and challenges. Biomaterials. 2017;146:168–182.
- Yang L, Webster TJ. Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin Drug Deliv. 2009;6:851–864.
- Bose S, Banerjee D, Bandyopadhyay A. Introduction to biomaterials and devices for bone disorders. Mater Devices Bone Disord. 2016. Available from: https://www.sciencedirect.com/science/article/pii/B978012802792900001X
- Mendonça G, DBS M, FJL A, et al. Advancing dental implant surface technology - from micron- to nanotopography. Biomaterials. 2008;29:3822–3835.
- Shen X, Ma P, Hu Y, et al. Alendronate-loaded hydroxyapatite-TiO2 nanotubes for improved bone formation in osteoporotic rabbits. J Mater Chem B. 2016;4(8):1423–1436.
- Tran N, Webster TJ. Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomater. 2011;7:1298–1306.
- Butoescu N, Seemayer CA, Foti M, et al. Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials. 2009;30:1772–1780.
- Kim MH, Na HK, Kim YK, et al. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano. 2011;5:3568–3576.
- Argyo C, Weiss V, Bräuchle C, et al. Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater. 2014;26:435–451.
- El-Fiqi A, Kim TH, Kim M, et al. Capacity of mesoporous bioactive glass nanoparticles to deliver therapeutic molecules. Nanoscale. 2012;4:7475.
- Wu C, Chang J. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application. Interface Focus. 2012;2:292–306.
- Hu Y, Cai K, Luo Z, et al. Layer-by-layer assembly of β-estradiol loaded mesoporous silica nanoparticles on titanium substrates and its implication for bone homeostasis. Adv Mater. 2010;22:4146–4150.
- Kose N, Çaylak R, Pekşen C, et al. Silver ion doped ceramic nano-powder coated nails prevent infection in open fractures: in vivo study. Injury. 2016;47:320–324.
- Medina-Cruz D, González MU, Tien-Street W, et al. Synergic antibacterial coatings combining titanium nanocolumns and tellurium nanorods. Nanomed Nanotechnol Biol Med [Internet]. 2019;17:36–46. [cited 2019 Jul 25]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30654187
- Wang G, Mostafa NZ, Incani V, et al. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases. J Biomed Mater Res Part A [Internet]. 2012;100A:684–693. [cited 2019 Jul 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22213565
- Zhang P, Zhang Y, Gao M, et al. Dendrimer-assisted hydrophilic magnetic nanoparticles as sensitive substrates for rapid recognition and enhanced isolation of target tumor cells. Talanta. 2016;161:925–931.
- Akbarzadeh A, Khalilov R, Mostafavi E, et al. Role of dendrimers in advanced drug delivery and biomedical applications: a review. Exp Oncol [Internet]. 2018;40:178–183. [cited 2019 Jun 26]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30285011
- Sun Y, Ye X, Cai M, et al. Osteoblast-targeting-peptide modified nanoparticle for siRNA/microRNA delivery. ACS Nano. 2016;10:5759–5768.
- Huang L, Wang X, Cao H, et al. A bone-targeting delivery system carrying osteogenic phytomolecule icaritin prevents osteoporosis in mice. Biomaterials. 2018;182:58–71.
- Ayre WN, Birchall JC, Evans SL, et al. A novel liposomal drug delivery system for PMMA bone cements. J Biomed Mater Res - Part B Appl Biomater. 2016;104:1510–1524.
- Riva R, Ragelle H, Des Rieux A, et al. Chitosan and chitosan derivatives in drug delivery and tissue engineering. Adv Polym Sci. 2011;244:19–44.
- Kalantari K, Afifi AM, Jahangirian H, et al. Biomedical applications of chitosan electrospun nanofibers as a green polymer – review. Carbohydr Polym. 2019;207:588–600.
- Gentile P, Nandagiri VK, Pabari R, et al. Influence of parathyroid hormone-loaded plga nanoparticles in porous scaffolds for bone regeneration. Int J Mol Sci. 2015;16:20492–20510.
- Gu W, Wu C, Chen J, et al. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Int J Nanomedicine. 2013;8:2305.
- Betancourt T, Byrne JD, Sunaryo N, et al. PEGylation strategies for active targeting of PLA/PLGA nanoparticles. J Biomed Mater Res A. 2009;91A:263–276.
- Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1-18.
- Samadikhah HR, Majidi A, Nikkhah M, et al. Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes. Int J Nanomedicine [Internet]. 2011;6:2275–2283. [cited 2019 Jul 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22072865
- Tang J, Chen J-Y, Liu J, et al. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency. Int J Pharm [Internet]. 2012;431:210–221. [cited 2019 Jul 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22561795
- Short AR, Koralla D, Deshmukh A, et al. Hydrogels That Allow and Facilitate Bone Repair, Remodeling, and Regeneration. J Mater Chem B [Internet]. 2015;3:7818–7830. [cited 2019 Jul 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26693013
- Bai X, Gao M, Syed S, et al. Bioactive hydrogels for bone regeneration. Bioact Mater [Internet]. 2018;3:401–417. [cited 2019 Jul 23]. Available from: https://www.sciencedirect.com/science/article/pii/S2452199X18300264
- Shin S-H, Purevdorj O, Castano O, et al. A short review: recent advances in electrospinning for bone tissue regeneration. J Tissue Eng [Internet]. 2012;3:2041731412443530. [cited 2019 Jul 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22511995
- Nedjari S, Awaja F, Altankov G. Three dimensional honeycomb patterned fibrinogen based nanofibers induce substantial osteogenic response of mesenchymal stem cells. Sci Rep [Internet]. 2017;7:15947. [cited 2019 Jul 23]. Available from: http://www.nature.com/articles/s41598-017-15956-8
- Waters R, Pacelli S, Maloney R, et al. Stem cell secretome-rich nanoclay hydrogel: a dual action therapy for cardiovascular regeneration. Nanoscale. 2016;8:7371–7376.
- Smith WR, Hudson PW, Ponce BA, et al. Nanotechnology in orthopedics: a clinically oriented review. BMC Musculoskelet Disord. 2018;19:67.
- Busatto S, Pham A, Suh A, et al. Organotropic drug delivery: synthetic nanoparticles and extracellular vesicles. Biomed Microdevices. 2019;21:46.
- Barry M, Pearce H, Cross L, et al. Advances in nanotechnology for the treatment of osteoporosis. Curr Osteoporos Rep. 2016;14:87–94.
- Jiang C, Jia J, Zhai S. Mechanistic understanding of toxicity from nanocatalysts. Int J Mol Sci [Internet]. 2014;15:13967–13992. [cited 2019 Jul 16]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25119861
- Sportelli MC, Izzi M, Volpe A, et al. The pros and cons of the use of laser ablation synthesis for the production of silver nano-antimicrobials. Antibiot (Basel, Switzerland) [Internet] 2018;7. [cited 2019 Jul 16]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30060553
- Ali A, Zafar H, Zia M, et al. Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl [Internet]. 2016;9:49–67. [cited 2019 Jul 16]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27578966
- Borm PJA, Robbins D, Haubold S, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol [Internet]. 2006;3:11. [cited 2019 Jul 16]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16907977
- Stander L, Theodore L. Environmental implications of nanotechnology–an update. Int J Environ Res Public Health [Internet]. 2011; 8:470–479. [cited 2019 Jul 1]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21556197.
- Anastas P, Eghbali N. Green chemistry: principles and practice. Chem Soc Rev [Internet]. 2010;39:301–312. [cited 2019 Jul 25]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20023854
- Saratale RG, Karuppusamy I, Saratale GD, et al. A comprehensive review on green nanomaterials using biological systems: recent perception and their future applications. Colloids Surf B Biointerfaces [Internet] 2018;170:20–35. [cited 2019 Feb 21]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29860217
- de la Guardia M. The challenges of green nanotechnology. Bioimpacts [Internet]. 2014;4:1–2. [cited 2019 Feb 21]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24790892
- Medina Cruz D, Mi G, Webster TJ. Synthesis and characterization of biogenic selenium nanoparticles with antimicrobial properties made by staphylococcus aureus, methicillin-resistant staphylococcus aureus (MRSA), escherichia coli, and pseudomonas aeruginosa. J Biomed Mater Res Part A [Internet]. 2018;106:1400–1412. [cited 2019 Jan 26]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29356322
- Thivaharan V, Ramesh V, Raja S. Green synthesis of silver nanoparticles for biomedical and environmental applications. Green Met. Nanoparticles [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2018. p. 287–439. [cited 2019 Jul 1].
- Das M, Chatterjee S. Green synthesis of metal/metal oxide nanoparticles toward biomedical applications: boon or bane. Green Synth Charact Appl Nanoparticles [Internet]. 2019;265–301. [cited 2019 Jul 1]. Available from:: https://www.sciencedirect.com/science/article/pii/B9780081025796000113
- Lomelí-Marroquín D, Medina Cruz D, Nieto-Argüello A, et al. Starch-mediated synthesis of mono- and bimetallic silver/gold nanoparticles as antimicrobial and anticancer agents. Int J Nanomedicine [Internet]. 2019;14:2171–2190. [cited 2019 Jun 21]. Available from: https://www.dovepress.com/starch-mediated-synthesis-of-mono–and-bimetallic-silvergold-nanoparti-peer-reviewed-article-IJN
- Liu Y, Deng F, Zhang L, et al. Sustained dual release of placental growth factor-2 and bone morphogenic protein-2 from heparin-based nanocomplexes for direct osteogenesis. Int J Nanomedicine [Internet]. 2016;11:1147. [cited 2019 Jun 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27042064
- Kim SE, Jeon O, Lee JB, et al. Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. J Biomed Sci [Internet]. 2008;15:771–777. [cited 2019 Jun 28]. Available from: http://www.springerlink.com/index/10.1007/s11373-008-9277-4
- Lee B-S, Lee -C-C, Wang Y-P, et al. Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs. Int J Nanomedicine [Internet]. 2016;11:285–297. [cited 2019 Jun 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26848264
- Valente JFA, Gaspar VM, Antunes BP, et al. Microencapsulated chitosan–dextran sulfate nanoparticles for controled delivery of bioactive molecules and cells in bone regeneration. Polymer (Guildf) [Internet]. 2013;54:5–15. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0032386112008889
- Gaur S, Wen Y, Song JH, et al. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy. Oncotarget [Internet]. 2015;6:29161–29177. [cited 2019 Jun 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26313360
- Lim TY, Wang W, Shi Z, et al. Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. J Mater Sci Mater Med [Internet]. 2009;20:1–10. [cited 2019 Jun 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18651113
- Shi Z, Neoh KG, Kang ET, et al. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules [Internet]. 2009;10:1603–1611. [cited 2019 Jun 28]. Available from: https://pubs.acs.org/doi/10.1021/bm900203w
- Fujioka-Kobayashi M, Ota MS, Shimoda A, et al. Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. Biomaterials [Internet]. 2012;33:7613–7620. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0142961212007259
- Dyondi D, Webster TJ, Banerjee R. A nanoparticulate injectable hydrogel as a tissue engineering scaffold for multiple growth factor delivery for bone regeneration. Int J Nanomedicine [Internet]. 2013;8:47–59. [cited 2019 Jun 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23293519
- Harris LG, Richards RG. Staphylococcus aureus adhesion to different treated titanium surfaces. J Mater Sci Mater Med [Internet]. 2004;15:311–314. [cited 2019 Jul 25]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15332591
- Foster TJ. The staphylococcus aureus “superbug”. J Clin Invest [Internet]. 2004;114:1693–1696. [cited 2019 Jul 25]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15599392
- Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci [Internet]. 2012;37:106–126. [cited 2019 Jun 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22125349
- Gonzalez-Fernandez T, Tierney EG, Cunniffe GM, et al. Gene delivery of TGF-β3 and BMP2 in an MSC-laden alginate hydrogel for articular cartilage and endochondral bone tissue engineering. Tissue Eng Part A [Internet]. 2016;22:776–787. [cited 2019 Jun 28]. Available from: https://www.liebertpub.com/doi/10.1089/ten.tea.2015.0576
- Nishida A, Yamada M, Kanazawa T, et al. Sustained-release of protein from biodegradable sericin film, gel and sponge. Int J Pharm [Internet] 2011;407:44–52. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0378517311000202
- Nishida A, Naganuma T, Kanazawa T, et al. The characterization of protein release from sericin film in the presence of an enzyme: towards fibroblast growth factor-2 delivery. Int J Pharm [Internet]. 2011;414:193–202. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0378517311004637
- Pankongadisak P, Suwantong O. The potential use of thermosensitive chitosan/silk sericin hydrogels loaded with longan seed extract for bone tissue engineering. RSC Adv. 2018;8:40219–40231.
- Curtin CM, Tierney EG, McSorley K, et al. Combinatorial gene therapy accelerates bone regeneration: non-viral dual delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold. Adv Healthc Mater [Internet]. 2015;4:223–227. [cited 2019 Jun 28]. Available from: http://doi.wiley.com/10.1002/adhm.201400397
- Raina DB, Larsson D, Mrkonjic F, et al. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: in-vitro and in-vivo carrier properties. J Control Release [Internet]. 2018;272:83–96. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0168365918300051
- Gonzalez-McQuire R, Green DW, Partridge KA, et al. Coating of human mesenchymal cells in 3D culture with bioinorganic nanoparticles promotes osteoblastic differentiation and gene transfection. Adv Mater [Internet]. 2007;19:2236–2240. [cited 2019 Jun 28].
- Yang X, Walboomers XF, van den Dolder J, et al. Non-Viral bone morphogenetic protein 2 transfection of rat dental pulp stem cells using calcium phosphate nanoparticles as carriers. Tissue Eng Part A [Internet]. 2008;14:71–81. [cited 2019 Jun 28]. Available from: https://www.liebertpub.com/doi/10.1089/ten.a.2007.0102
- Sheikh L, Sinha S, Singhababu YN, et al. Traversing the profile of biomimetically nanoengineered iron substituted hydroxyapatite: synthesis, characterization, property evaluation, and drug release modeling. RSC Adv [Internet]. 2018;8:19389–19401. [cited 2019 Jun 28]. Available from: http://xlink.rsc.org/?DOI=C8RA01539B
- Slowing II, Vivero-Escoto JL, Wu C-W, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev [Internet]. 2008;60:1278–1288. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0169409X08000951
- Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem A Eur J [Internet]. 2006;12:5934–5943. [cited 2019 Jun 28]. Available from: http://doi.wiley.com/10.1002/chem.200600226
- Vallet-Regí M, Balas F, Colilla M, et al. Bone-regenerative bioceramic implants with drug and protein controlled delivery capability. Prog Solid State Chem [Internet]. 2008;36:163–191. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0079678607000684#bib68
- Mann AP, Tanaka T, Somasunderam A, et al. E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow. Adv Mater [Internet]. 2011;23:H278–H282. [cited 2019 Jun 28]. Available from: http://doi.wiley.com/10.1002/adma.201101541
- Czarnobaj K, Prokopowicz M, Greber K, et al. Use of materials based on polymeric silica as bone-targeted drug delivery systems for metronidazole. Int J Mol Sci [Internet]. 2019;20:1311. [cited 2019 Jun 28]. Available from: https://www.mdpi.com/1422-0067/20/6/1311
- Yao Q, Liu Y, Selvaratnam B, et al. Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering. J Control Release [Internet]. 2018;279:69–78. [cited 2019 Jun 28]. Available from: https://www.sciencedirect.com/science/article/pii/S0168365918301937